MedTech Terms
    The authoritative reference
    All terms
    ManufacturingManufacturing & SupplyECO / ECN

    Engineering Change Order / Notice

    Documents that authorize and communicate changes to released designs, BOMs, or manufacturing processes.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    ECO/ECN processes are the practical mechanism behind the 21 CFR 820.30(i) and ISO 13485 §7.3.9 design change requirements. They link the change request to impact analysis, approvals, training, and effectivity.
    What the regulation says
    Regulators view Engineering Change Orders (ECOs) or Engineering Change Notices (ECNs) as critical controls for managing design changes throughout a medical device's lifecycle. The FDA's 21 CFR 820.30(i) mandates procedures for design changes, while ISO 13485:2016 clause 7.3.9 requires control of design and development changes. These regulations emphasize documenting, verifying, validating, and approving changes before implementation, ensuring continued safety and effectiveness of the device.

    What this means in practice

    PLM systems automate ECO routing; weak effectivity tracking leads to mixed-revision inventory and field issues.

    Examples

    • An ECO is initiated to update the firmware of an infusion pump to fix a software bug identified during post-market surveillance, requiring re-validation and regulatory submission.
    • An ECN is raised to change a material supplier for a critical component of a surgical instrument, necessitating a re-evaluation of biocompatibility and performance.
    • A manufacturer uses an ECO to implement a minor aesthetic change to a device’s packaging, which still requires documented approval but may not trigger extensive re-testing.
    Common pitfalls
    • •Failing to assess the full impact of a change across all relevant product documentation, manufacturing processes, and supplier agreements is a common pitfall.
    • •Implementing a change without adequate verification or validation can lead to product non-conformities and patient safety issues.
    • •Not involving all necessary stakeholders, such as regulatory, quality, R&D, and manufacturing teams, in the ECO/ECN process can result in overlooked requirements or implementation challenges.
    • •Poor control over effectivity dates can result in mixed inventory, making it difficult to trace which product versions are in the field and comply with specific change implementations.
    • •Treating minor changes with the same rigorous process as major ones, or conversely, not giving sufficient attention to cumulative minor changes, can bottleneck operations or introduce uncontrolled risk.

    Frequently asked questions

    The primary purpose is to provide a structured and documented process for managing alterations to a medical device's design, specifications, or manufacturing processes, ensuring compliance with regulatory requirements and maintaining product safety and efficacy.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    eCFR·1FDA·1ISO·1
    1. 1
      21 CFR 820.30(i)
      Verified
      eCFRecfr.gov
    2. 2
      FDA - Device Manufacturing
      Verified
      FDAfda.gov
    3. 3
      ISO 13485 Standard Page
      Verified
      ISOiso.org

    Inline markers like [1] jump to the matching reference above.